Lv1
46 积分 2025-12-05 加入
CD48 is a novel immune checkpoint on tumour‐associated macrophages in hepatocellular carcinoma
4个月前
已完结
Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
4个月前
已完结
In Situ Chimeric Antigen Receptor Macrophage Therapy via Co-Delivery of mRNA and Immunostimulant
5个月前
已完结
Engineering myeloid cells for cancer immunotherapy
5个月前
已完结
皖公网安备34019202002308
